Get started
Author

Marta Turati

Observed names: M. Turati, Turati, Marta
Observed institution: University of Brescia
ORCID: 0000-0002-7139-3820
Observed ORCID: 0000-0002-7139-3820
OpenAlex ID: A5047882670
TGF-β mediated drug resistance in solid cancer
2023 · Marta Turati, Alexandra Mousset, et al. · Cytokine & Growth Factor Reviews · 49
PDF
Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression
2019 · Sara Matarazzo, Laura Melocchi, et al. · Cancers · 33
PDF
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer
2023 · Federica Maccarinelli, Daniela Coltrini, et al. · Cell Death Discovery · 30
PDF
Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells
2022 · Francesco Liguori, Simone Carradori, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 28
PDF
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer
2021 · Paola Chiodelli, Daniela Coltrini, et al. · Cancer Letters · 21
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1 H -pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells
2023 · Domiziana Masci, Michela Puxeddu, et al. · Journal of Medicinal Chemistry · 19
PDF
Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity
2024 · Simone Giovannuzzi, Anna Nikitjuka, et al. · Journal of Medicinal Chemistry · 16
Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives
2022 · Alessandra Loda, Marta Turati, et al. · International Journal of Molecular Sciences · 16
PDF
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
2023 · Arianna Giacomini, Marta Turati, et al. · Experimental Hematology and Oncology · 14
PDF
An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo
2025 · Giorgia Gazzaroli, Camilla Tavani, et al. · Experimental Hematology and Oncology · 10
PDF
PTX3 shapes profibrotic immune cells and epithelial/fibroblast repair and regeneration in a murine model of pulmonary fibrosis
2023 · Antonio d’Amati, Roberto Ronca, et al. · Pathology - Research and Practice · 8
PDF
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination
2022 · Marta Turati, Arianna Giacomini, et al. · Experimental Hematology and Oncology · 5
PDF
A novel mertansine conjugate for acid-reversible targeted drug delivery validated through the Avidin-Nucleic-Acid-NanoASsembly platform
2024 · Elisa Schiavon, Sara Rezzola, et al. · Nanomedicine Nanotechnology Biology and Medicine · 4
Molecular Profiling of Lymphatic Endothelial Cell Activation In Vitro
2023 · Marta Turati, Gianluca Mattei, et al. · International Journal of Molecular Sciences · 4
PDF
NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation
2026 · Lorenzo Manfreda, Fatlum Rruga, et al. · Redox Biology · 2
PDF
A Glucosylated BODIPY Uses the GLUT Channel to Target Cancer Cells in In Vitro and In Vivo Models
2025 · Marta Turati, Giacomo Biagiotti, et al. · ACS Omega · 2
PDF
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma
2025 · Sara Taranto, Jessica Faletti, et al. · Biomedicine & Pharmacotherapy · 2
4‐(5‐Chloro‐3‐(3,4,5‐trimethoxybenzoyl)‐1 H ‐indol‐1‐yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β‐Catenin Signaling Pathway, and P‐Glycoprotein
2026 · Michela Puxeddu, Rosa Bordone, et al. · ChemMedChem · 1
Potent carbonic anhydrase inhibition by ruthenium(II)-acetazolamide conjugates uncoupled from antiproliferative activity in vitro
2025 · Alberto Gobbo, Simone Giovannuzzi, et al. · Chemico-Biological Interactions · 1
The FGF/FGFR System in the Biology and Therapeutic Landscape of Pediatric CNS Tumors
2026 · Serena Filiberti, Camilla Tavani, et al. · Medicinal Research Reviews
A PTX3/TLR4 axis sustains sonic hedgehog-medulloblastoma growth and defines a new therapeutic vulnerability
2026 · Serena Filiberti, Camilla Tavani, et al. · Neuro-Oncology
SEL1L exerts a pro-tumorigenic/pro-angiogenic function in human skin melanoma
2026 · Daniela Coltrini, Mirella Belleri, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Phytocannabinoids restore enzalutamide responsiveness in high-fat diet-driven prostatecancer with gut microbiota remodeling
2026 · Magdalena Kostrzewa, Roberto Ronca, et al. · SSRN Electronic Journal
Corrigendum to “FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma” [Biomed. Pharmacother. 192 (2025) 118677]
2025 · Sara Taranto, Jessica Faletti, et al. · Biomedicine & Pharmacotherapy
FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma
2025 · Taranto, Sara, Faletti, Jessica, et al. · Zurich Open Repository and Archive (University of Zurich)
Works count: 33
Citation count: 265
H-index: 10
I10-index: 10
Year
Topic
Type